205 related articles for article (PubMed ID: 28482784)
21. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
22. Recent developments in ocular drug delivery.
Chen H
J Drug Target; 2015; 23(7-8):597-604. PubMed ID: 26453157
[TBL] [Abstract][Full Text] [Related]
23. Review on the systemic delivery of insulin via the ocular route.
Lee YC; Simamora P; Pinsuwan S; Yalkowsky SH
Int J Pharm; 2002 Feb; 233(1-2):1-18. PubMed ID: 11897405
[TBL] [Abstract][Full Text] [Related]
24. Polysaccharide-Based Nanocarriers for Ocular Drug Delivery.
Formica ML; Calles JA; Palma SD
Curr Pharm Des; 2015; 21(33):4851-68. PubMed ID: 26290208
[TBL] [Abstract][Full Text] [Related]
25. Ocular drug delivery-eye on innovation.
Rupenthal ID; O'Rourke M
Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597
[No Abstract] [Full Text] [Related]
26. Recent Advances in Topical Ocular Drug Delivery.
Yellepeddi VK; Palakurthi S
J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
[TBL] [Abstract][Full Text] [Related]
27. Turning the screw even further to increase microparticle retention and ocular bioavailability of associated drugs: The bioadhesion goal.
Rodríguez Villanueva J; Rodríguez Villanueva L
Int J Pharm; 2017 Oct; 531(1):167-178. PubMed ID: 28822703
[TBL] [Abstract][Full Text] [Related]
28. In vitro testing of thiolated poly(aspartic acid) from ophthalmic formulation aspects.
Budai-Szű Cs M; Horvát G; Gyarmati B; Szilágyi BÁ; Szilágyi A; Csihi T; Berkó S; Szabó-Révész P; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
Drug Dev Ind Pharm; 2016 Aug; 42(8):1241-6. PubMed ID: 26556306
[TBL] [Abstract][Full Text] [Related]
29. Controlled and continuous release ocular drug delivery systems: pros and cons.
Abdelkader H; Alany RG
Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
[TBL] [Abstract][Full Text] [Related]
30. Manufacturing techniques of biodegradable implants intended for intraocular application.
Fialho SL; da Silva Cunha A
Drug Deliv; 2005; 12(2):109-16. PubMed ID: 15824036
[TBL] [Abstract][Full Text] [Related]
31. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
32. Nanocrystal for ocular drug delivery: hope or hype.
Sharma OP; Patel V; Mehta T
Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
[TBL] [Abstract][Full Text] [Related]
33. A review on therapeutic contact lenses for ocular drug delivery.
Maulvi FA; Soni TG; Shah DO
Drug Deliv; 2016 Oct; 23(8):3017-3026. PubMed ID: 26821766
[TBL] [Abstract][Full Text] [Related]
34. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond.
Destruel PL; Zeng N; Maury M; Mignet N; Boudy V
Drug Discov Today; 2017 Apr; 22(4):638-651. PubMed ID: 28017837
[TBL] [Abstract][Full Text] [Related]
36. Drug Delivery for Ocular Allergy: Current Formulation Design Strategies and Future Perspectives.
Regu VR; Swain RP; Subudhi BB
Curr Pharm Des; 2023; 29(33):2626-2639. PubMed ID: 37936454
[TBL] [Abstract][Full Text] [Related]
37. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
Andonova VY
Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
[TBL] [Abstract][Full Text] [Related]
38. Advances in ophthalmic drug delivery.
Morrison PW; Khutoryanskiy VV
Ther Deliv; 2014 Dec; 5(12):1297-315. PubMed ID: 25531930
[TBL] [Abstract][Full Text] [Related]
39. A New Vision for the Eye: Unmet Ocular Drug Delivery Needs.
Rivers HM; Ray Chaudhuri S; Shah JC; Mittal S
Pharm Res; 2015 Sep; 32(9):2814-23. PubMed ID: 26055402
[No Abstract] [Full Text] [Related]
40. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
